Brand Name Big Pharma Giant Surpasses Expectations After Hiking Prices

A new third quarter earnings report released today from Big Pharma giant GlaxoSmithKline (GSK) demonstrates yet again that price hikes continue to support big time profits for brand name drug companies.  The pharmaceutical manufacturer beat Wall Street expectations for the third quarter of 2020.

The strong earnings report comes as the company has continued to hike prices on prescription drugs.

See how other brand name drug Merck, Novartis, Pfizer and Johnson & Johnson beat Wall Street expectations after hiking prices on American patients HERE and HERE.

Stay tuned as we continue to monitor Q3 earnings announcements from brand name drug companies.

Sign-up for updates

  • This field is for validation purposes and should be left unchanged.